4//SEC Filing
LEDERMAN SETH 4
Accession 0001387131-22-007441
CIK 0001430306other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:05 PM ET
Size
10.5 KB
Accession
0001387131-22-007441
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorPresident and CEO
Transactions
- Purchase
Common Stock, $0.001 par value
2022-06-29$1.71/sh+20,000$34,200→ 24,235 total(indirect: By IRA)
Holdings
- 1(indirect: By Leder Laboratories, Inc.)
Common Stock, $0.001 par value
- 2(indirect: By LLC)
Common Stock, $0.001 par value
- 7(indirect: By LLC)
Common Stock, $0.001 par value
- 2(indirect: By LLC)
Common Stock, $0.001 par value
- 1(indirect: By Spouse)
Common Stock, $0.001 par value
- 3,505
Common Stock, $0.001 par value
- 1(indirect: By Starling Pharmaceuticals, Inc.)
Common Stock, $0.001 par value
Footnotes (2)
- [F1]Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022.
- [F2]Reporting person may be deemed to be a control person of this entity.
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001563420
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:05 PM ET
- Size
- 10.5 KB